NinZA | Theranostic molecular zipper based switchable nanomedicine for overcoming drug resistance

Summary
This Fellowship will bring an outstanding researcher from Sweden to the UK to gain new scientific and career skills to position him to become a leading independent academic in the interface of chemistry and biology for translational Nanomedicine. The fellow will design a new class of biomimetic zipper nano-architecture, combining an MRI-enabled SPION scaffold with a zip-unzip, temperature and pH-responsive multi-arm polymer to defuse drug resistant cell functions. These approach could greatly benefit the current investigation of new and alternate therapeutic procedures to overcome drug resistance. The fellow will gain advanced training in translational designs of drugs for recognition and treatment of drug resistant system, and in state of the art techniques for studying such system.
Combined with the fellow's knowledge of nanoparticles in medicine, he will have a formidable skill set suited to designing nano-architectures for developing target-specific nano-drugs to push back frontiers in the battle against cancer. His excellent track record is in consistent with last two years performance with 4 publications (with cumulative IF>28) with leading publishers including Nature group, Wiley, Cell press etc., 1 cover page and cover story, one Keynote lecture and 2 international research competition awards (FEBS Young scientist forum and Nano Today, Elsevier ST award). A series of complementary career skills trainings will enhance the fellow's research management, leadership, presentation and teaching skills and make him an impressive and exciting candidate for an independent EU academic position.
Unfold all
/
Fold all
More information & hyperlinks
Web resources: https://cordis.europa.eu/project/id/706694
Start date: 15-04-2017
End date: 14-04-2019
Total budget - Public funding: 195 454,80 Euro - 195 454,00 Euro
Cordis data

Original description

This Fellowship will bring an outstanding researcher from Sweden to the UK to gain new scientific and career skills to position him to become a leading independent academic in the interface of chemistry and biology for translational Nanomedicine. The fellow will design a new class of biomimetic zipper nano-architecture, combining an MRI-enabled SPION scaffold with a zip-unzip, temperature and pH-responsive multi-arm polymer to defuse drug resistant cell functions. These approach could greatly benefit the current investigation of new and alternate therapeutic procedures to overcome drug resistance. The fellow will gain advanced training in translational designs of drugs for recognition and treatment of drug resistant system, and in state of the art techniques for studying such system.
Combined with the fellow's knowledge of nanoparticles in medicine, he will have a formidable skill set suited to designing nano-architectures for developing target-specific nano-drugs to push back frontiers in the battle against cancer. His excellent track record is in consistent with last two years performance with 4 publications (with cumulative IF>28) with leading publishers including Nature group, Wiley, Cell press etc., 1 cover page and cover story, one Keynote lecture and 2 international research competition awards (FEBS Young scientist forum and Nano Today, Elsevier ST award). A series of complementary career skills trainings will enhance the fellow's research management, leadership, presentation and teaching skills and make him an impressive and exciting candidate for an independent EU academic position.

Status

CLOSED

Call topic

MSCA-IF-2015-EF

Update Date

28-04-2024
Geographical location(s)
Structured mapping
Unfold all
/
Fold all
EU-Programme-Call
Horizon 2020
H2020-EU.1. EXCELLENT SCIENCE
H2020-EU.1.3. EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions (MSCA)
H2020-EU.1.3.2. Nurturing excellence by means of cross-border and cross-sector mobility
H2020-MSCA-IF-2015
MSCA-IF-2015-EF Marie Skłodowska-Curie Individual Fellowships (IF-EF)